CSc1c(C#N)c(N)nc2c(/N=N\c3ccc(Cl)cc3)c(N)nn12
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?